Target Name: BIN3
NCBI ID: G55909
Review Report on BIN3 Target / Biomarker Content of Review Report on BIN3 Target / Biomarker
BIN3
Other Name(s): BIN3_HUMAN | bridging integrator 3 | Bridging integrator 3, transcript variant 1 | Bridging integrator 3 (isoform 1) | BIN3 variant 1 | Bridging integrator 3 | Bridging integrator 3 (BIN3)

BIN3: A Potential Drug Target and Biomarker

BIN3 (BIN3_HUMAN), a protein that is expressed in various tissues and cells of the human body, is a potential drug target or biomarker. Its function and significance have been attracting attention in recent years due to its involvement in various biological processes. In this article, we will explore the potential implications of BIN3 as a drug target and its potential use as a biomarker.

The protein BIN3 is a key regulator of the microtubule network, which is a complex system of filaments that transports vesicles and other cellular structures within the cell. Microtubules play a critical role in cell division, intracellular transport, and regulation of various cellular processes. BIN3 is a key component of the microtubule network and is responsible for regulating the dynamics of microtubules.

One of the key functions of BIN3 is its role in the regulation of mitosis. BIN3 is involved in the regulation of mitosis spindle assembly and depolymerization, which are critical for the proper separation of chromosomes during the cell division process. BIN3 has been shown to play a critical role in the regulation of mitosis by regulating the stability of the microtubules and the interaction between the microtubules and the chromatin.

BIN3 is also involved in the regulation of cell migration. Microtubules play a critical role in the regulation of cell migration, as they help to push the cells along the track and control the direction of their movement. BIN3 is involved in the regulation of microtubule dynamics. and has been shown to play a critical role in the regulation of cell migration.

In addition to its role in cell division and migration, BIN3 is also involved in the regulation of various other cellular processes. BIN3 has been shown to be involved in the regulation of cell adhesion, cell signaling, and neurotransmission.

Given its involvement in various cellular processes, BIN3 is a potential drug target. Drugs that target BIN3 have the potential to inhibit its function and disrupt various cellular processes. This could have a wide range of potential therapeutic applications, including the treatment of various diseases.

In addition to its potential as a drug target, BIN3 may also be a useful biomarker for certain diseases. BIN3 is expressed in various tissues and cells of the human body, including brain, heart, and liver. This makes it a potential biomarker for a wide range of diseases. For example, BIN3 has been shown to be expressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that BIN3 may be a useful biomarker for the diagnosis and treatment of cancer.

In conclusion, BIN3 is a protein that is involved in various cellular processes and has the potential as a drug target or biomarker. Its role in the regulation of cell division, migration, and other cellular processes makes it a potential target for a wide range of drugs. In addition, its expression in various tissues and cells of the human body makes it a potential biomarker for the diagnosis and treatment of various diseases. Further research is needed to fully understand the potential implications of BIN3 as a drug target and biomarker.

Protein Name: Bridging Integrator 3

Functions: Involved in cytokinesis and septation where it has a role in the localization of F-actin

The "BIN3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BIN3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

BIN3-IT1 | Biogenesis of lysosome-related organelles complex-1 | BIRC2 | BIRC3 | BIRC5 | BIRC6 | BIRC7 | BIRC8 | BISPR | BIVM | BIVM-ERCC5 | BLACAT1 | BLACE | BLCAP | BLID | BLK | BLM | BLMH | BLNK | BLOC-1 (biogenesis of lysosome-related organelles complex 1) | BLOC1S1 | BLOC1S1-RDH5 | BLOC1S2 | BLOC1S3 | BLOC1S4 | BLOC1S5 | BLOC1S5-TXNDC5 | BLOC1S6 | BLTP1 | BLTP2 | BLTP3A | BLTP3B | BLVRA | BLVRB | BLZF1 | BMAL1 | BMAL2 | BMAL2-AS1 | BMERB1 | BMF | BMI1 | BMP1 | BMP10 | BMP15 | BMP2 | BMP2K | BMP3 | BMP4 | BMP5 | BMP6 | BMP7 | BMP8A | BMP8B | BMPER | BMPR1A | BMPR1B | BMPR1B-DT | BMPR2 | BMS1 | BMS1P1 | BMS1P10 | BMS1P14 | BMS1P15 | BMS1P17 | BMS1P18 | BMS1P2 | BMS1P20 | BMS1P21 | BMS1P22 | BMS1P4 | BMS1P7 | BMS1P8 | BMT2 | BMX | BNC1 | BNC2 | BNC2-AS1 | BNIP1 | BNIP2 | BNIP3 | BNIP3L | BNIP5 | BNIPL | BOC | BOD1 | BOD1L1 | BOD1L2 | BOK | BOK-AS1 | BOLA1 | BOLA2 | BOLA2B | BOLA3 | BOLA3-DT | BOLL | Bombesin receptor | Bone morphogenetic protein (BMP) | Bone Morphogenetic Protein Receptor | Bone Morphogenetic Protein Receptor Type I | BOP1